<html>
<b><br>
</b><font face="Arial, Helvetica">The eCheminfo Community of Practice
InterAction Meeting "Latest Advances in Drug Discovery &
Development" will take place 16-19 October 2006, Bryn Mawr,
Philadelphia, USA. <br>
<br>
The eCheminfo InterAction meeting will discuss the latest developments in
virtual screening, structure-based drug design, reaction planning,
medicinal chemistry and predictive toxicology supporting decision making
in drug discovery & development. The meeting brings together
researchers, industry experts and managers, academics and solution
providers with a common interest of improving the productivity and
effectiveness of modeling and informatics methods in drug discovery,
design and development. In addition to meeting presentations, significant
time at meetings is reserved for panel discussions, workshops, and
evening poster session and networking activities.<br>
<br>
A parallel InnovationWell Meeting on "Innovation in Life Science
& Healthcare Research & Product Development" will also take
place at the same location on the same dates. The InnovationWell Program
will be concentrating on themes of relevance to FDA’s Critical Path
initiative including topics in Knowledge Management in Clinical and
Translational Research, Decision Support for R&D, Metabolomics,
Predictive Toxicology and Biomarkers & Systems Biology approaches.
<br>
<br>
Confirmed Speakers at the Bryn Mawr meeting include: <br>
Frank Hollinger (Locus Pharmaceuticals), Erin Duffy (Rib-X), Mike Malams
(Wyeth), Debananda Das (NCI), Max Cummings (Johnson & Johnson
PR&D), Lance Westerhoff (QuantumBio), Jose Duca (Schering-Plough),
Osman Guner (Turquoise Consulting), Hege Beard (Schrodinger), Stan Young
(NISS), John Irwin (UCSF), William Douglas Figg (NCI), Daryll Reid
(Simbiosys), Gregory Warren (GlaxoSmithKline), Deepak Bandyopadhyay
(Johnson & Johnson PR&D), Paul Hawkins (OpenEye), Chris Cooper
(BMS), James Arnold (Astra-Zeneca), Phil Edwards (Astra-Zeneca), Pete
Connolly (Johnson & Johnson PR&D), Michael Farnum (Johnson &
Johnson PRD), Jim Wikel (Coalesix), Tudor Oprea (Univ. New Mexico), Alex
Tropsha (UNC), Curt Breneman (RPI), Sanji Bhal (ACD/Labs), Michael Bolger
(Simulations Plus), Bob Clark (Tripos), Gilles Klopman (Multicase),
Navita Mallalieu (Roche Pharmaceuticals), Deepak Bandyopadhyay (Johnson
& Johnson PR&D), Zentam Tsuchihashi (BMS), Peter Henstock
(Pfizer), Darius Dziuda (Multivariate bioMarkers Discovery), Keith
Elliston (Genstruct), Michael Jones (Novartis), Ansgar J. Pommer
(SkinSysTec), Bernd Bonnekoh (Otto-von-Guericke-University), Michael
Liebman (Windber Research Institute), Jonathan Sheldon (InforSense),
Duane Shugars (Concentia Digital), Jian Wang (Biofortis), Peter Gates
(Johnson & Johnson PR&D), Barry Hardy (Douglas Connect), Dennis
Underwood (Praxeon), Jeff Spitzner (Rescentris), David Mosenkis
(Spotfire), Joel Hoffman (IntraSphere), Delia Wolf (Harvard Medical
School), Craig Liddell (Epacris), Joseph Bitran (Enterprizer), Alvin
Berger (Metabolon), Gregory Banik (Bio-RAD), George Harrigan (Monsanto),
Rick Beger (NCTR, FDA), Don Robertson (Pfizer), Teresa Garret (Duke
University), Greg Maguire (SIDMAP), Bruce Kristal (Cornell University),
Andrew Lane (JG Brown Cancer Center, U. Louisville), Eric Nemec (Leco
Corporation), Oliver Fiehn (UC Davis Genome Center), Susan Connor (Glaxo
SmithKline)<br>
<br>
A poster session will take place on the evening of 18 October. Abstracts
should be submitted to eCheminfo [at] douglasconnect.com<br>
<br>
For those unable to attend the whole meeting special one or two day
passes at reduced registration fee rates may be arranged with the
conference secretariat. Academic discounts are offered. (Please
contact Nicki.Douglas [at] douglasconnect.com)<br>
<br>
</font>Program (as pdfs):<br>
Latest Advances in Drug Discovery & Development<br>
<i>Bryn Mawr College, Philadelphia, PA (16-19 October 2006)<br>
</i><font color="#0000FF"><u><a href="http://barryhardy.blogs.com/cheminfostream/files/eChemProgramBrynMawr06-web1a4.PDF" eudora="autourl">http://barryhardy.blogs.com/cheminfostream/files/eChemProgramBrynMawr06-web1a4.PDF</a><br>
</u></font>AND<br>
Innovation in Life Science & Healthcare Research & Product
Development<br>
<i>Bryn Mawr College, Philadelphia, PA (16-19 October 2006)<br>
</i><font color="#0000FF"><u><a href="http://barryhardy.blogs.com/theferryman/files/innwprogrambrynmawr06final_web2.pdf" eudora="autourl">http://barryhardy.blogs.com/theferryman/files/innwprogrambrynmawr06final_web2.pdf</a><br>
<br>
</u></font>The detailed agenda for the meeting with linked abstracts are
provided at the following links:<br>
<font color="#0000FF"><u><a href="http://www.innovationwell.net/COMTY_conferenceprogram/" eudora="autourl">http://www.innovationwell.net/COMTY_conferenceprogram/</a><br>
</u></font>and<br>
<font color="#0000FF"><u><a href="http://www.echeminfo.com/COMTY_conferenceprogram/" eudora="autourl">http://www.echeminfo.com/COMTY_conferenceprogram/</a></u></font>
<br>
<br>
Updates are provided at the following Blog links:<br>
Cheminfostream Blog:<br>
<font color="#0000FF"><u><a href="http://barryhardy.blogs.com/cheminfostream/" eudora="autourl">http://barryhardy.blogs.com/cheminfostream/</a><br>
</u></font>Ferryman Blog<br>
<font color="#0000FF"><u><a href="http://barryhardy.blogs.com/theferryman/" eudora="autourl">http://barryhardy.blogs.com/theferryman/</a><br>
<br>
<br>
</u></font>best regards<br>
Barry Hardy<br>
<br>
<br>
Douglas Connect<br>
Baermeggenweg 14<br>
Zeiningen, CH-4314<br>
Switzerland<br>
Tel: +41 61 851 0170<br>
</html>